In colorectal cancer models, it is known that tumor-secreted CTSK can bind to Toll-like receptor 4 (TLR4) on the surface of macrophages and promote M2 polarization through a mammalian target of rapamycin (mTOR)-dependent pathway 34. Here, MTOR is linked to neoplasm.